Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
| Status: | Completed |
|---|---|
| Conditions: | Blood Cancer, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | June 2004 |
| End Date: | December 2012 |
| Contact: | BMT Referrals |
| Phone: | (650) 723-0822 |
The purpose of the study is to determine if the use of activated T cells can effectively
treat relapsed disease following allogeneic hematopoietic cell transplantation without
causing GVHD.
Inclusion Criteria:- Evidence of recurrent or persistent hematologic malignancy following
HLA matched allogeneic hematopoietic cell transplant
- eligible for DLI
- no evidence of GVHD
- stable immunosuppressive regimen
- adequate renal and liver function
Exclusion Criteria:- CML patients who have not received DLI, active infections
We found this trial at
1
site
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
